ATE424410T1 - Interleukin-19. - Google Patents

Interleukin-19.

Info

Publication number
ATE424410T1
ATE424410T1 AT96932967T AT96932967T ATE424410T1 AT E424410 T1 ATE424410 T1 AT E424410T1 AT 96932967 T AT96932967 T AT 96932967T AT 96932967 T AT96932967 T AT 96932967T AT E424410 T1 ATE424410 T1 AT E424410T1
Authority
AT
Austria
Prior art keywords
interleukin
polypeptides
vectors
nucleic acid
producing
Prior art date
Application number
AT96932967T
Other languages
English (en)
Inventor
Craig Rosen
Joseph Kenny
Original Assignee
Human Genome Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Human Genome Sciences Inc filed Critical Human Genome Sciences Inc
Application granted granted Critical
Publication of ATE424410T1 publication Critical patent/ATE424410T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/026—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT96932967T 1996-08-30 1996-08-30 Interleukin-19. ATE424410T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1996/014355 WO1998008870A1 (en) 1996-08-30 1996-08-30 Interleukin-19

Publications (1)

Publication Number Publication Date
ATE424410T1 true ATE424410T1 (de) 2009-03-15

Family

ID=22255746

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96932967T ATE424410T1 (de) 1996-08-30 1996-08-30 Interleukin-19.

Country Status (10)

Country Link
EP (2) EP2065396A1 (de)
JP (1) JP2001500369A (de)
AT (1) ATE424410T1 (de)
AU (1) AU7155296A (de)
CA (1) CA2264548A1 (de)
DE (1) DE69637856D1 (de)
DK (1) DK0963377T3 (de)
ES (1) ES2322877T3 (de)
PT (1) PT963377E (de)
WO (1) WO1998008870A1 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1247780C (zh) * 1997-11-26 2006-03-29 津莫吉尼蒂克斯公司 哺乳动物细胞因子样多肽－10
US6576743B1 (en) 1997-11-26 2003-06-10 Zymogenetics, Inc. Mammalian cytokine-like polypeptide-10
CA2374341A1 (en) * 1999-05-20 2000-11-30 Takeda Chemical Industries, Ltd. Novel polypeptide
US7122632B2 (en) 1999-12-23 2006-10-17 Zymogenetics, Inc. Soluble Interleukin-20 receptor
GB0020498D0 (en) 2000-08-18 2000-10-11 Sterix Ltd Compound
CA2467723C (en) 2001-12-17 2011-09-27 Zymogenetics, Inc. Method for treating cervical cancer
US7074575B2 (en) * 2002-04-11 2006-07-11 Zymogenetics, Inc. Use of interleukin-19 to treat ovarian cancer
DE602004023965D1 (de) 2003-11-21 2009-12-17 Zymogenetics Inc Anti-il-20-antikörper und bindungspartner und verfahren zur anwendung bei entzündungen
CA2549306A1 (en) * 2003-12-03 2005-07-07 Schering Corporation Methods of modulating cytokine activity; related reagents
EP2033662B1 (de) 2004-01-21 2012-10-17 Novo Nordisk Health Care AG Transglutaminase vermittelte konjugation von peptiden.
GB0411562D0 (en) 2004-05-24 2004-06-23 Sterix Ltd Compound
GB0412492D0 (en) 2004-06-04 2004-07-07 Sterix Ltd Compound
GB0513702D0 (en) 2005-07-04 2005-08-10 Sterix Ltd Compound
GB0702446D0 (en) 2007-02-08 2007-03-21 Sterix Ltd Composition
GB0706072D0 (en) 2007-03-28 2007-05-09 Sterix Ltd Compound
GB0722779D0 (en) 2007-11-20 2008-01-02 Sterix Ltd Compound
GB0914767D0 (en) 2009-08-24 2009-09-30 Sterix Ltd Compound
BR112012021576A2 (pt) 2010-02-26 2016-10-25 Novo Nordisk As composições estáveis contendo anticorpo.
RU2012153786A (ru) 2010-05-28 2014-07-10 Ново Нордиск А/С Стабильные многодозовые композиции, содержащие антитело и консервант
CN111647081B (zh) * 2020-04-28 2022-06-03 武汉百杰康生物科技有限公司 一种重组小鼠抗人白介素19单克隆抗体、制备方法和应用
EP3964265A1 (de) * 2020-09-07 2022-03-09 Fundacion Instituto De Investigacion Sanitaria Fundacion Jimenez Diaz Mesenchymale stammzellen, die cxcr4 und il-10 co-exprimieren, und verwendungen davon

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4381295A (en) 1979-04-26 1983-04-26 Ortho Pharmaceutical Corporation Monoclonal antibody to human helper T cells and methods of preparing same
US4361549A (en) 1979-04-26 1982-11-30 Ortho Pharmaceutical Corporation Complement-fixing monoclonal antibody to human T cells, and methods of preparing same
US4486530A (en) 1980-08-04 1984-12-04 Hybritech Incorporated Immunometric assays using monoclonal antibodies
US4433092A (en) 1981-03-09 1984-02-21 Champion Spark Plug Company Green ceramic of lead-free glass, conductive carbon, silicone resin and AlPO4, useful, after firing, as an electrical resistor
US4483920A (en) 1982-05-17 1984-11-20 Hahnemann University Immobilization of message RNA directly from cells onto filter material
DE3586772T2 (de) 1984-07-24 1993-03-04 Coselco Mimotopes Pty Ltd Verfahren zur bestimmung von mimotopen.
US4631211A (en) 1985-03-25 1986-12-23 Scripps Clinic & Research Foundation Means for sequential solid phase organic synthesis and methods using the same
EP0232262A4 (de) 1985-08-15 1989-09-19 Stauffer Chemical Co Tryptophan erzeugender mikroorganismus.
LU86128A1 (fr) 1985-10-18 1987-06-02 Vander Poorten Henri Procede permettant l'impression ou le revetement de ceramique simultanement a son electroformage et conduisant en monocuisson a des produits decoratifs ou techniques
EP0394827A1 (de) 1989-04-26 1990-10-31 F. Hoffmann-La Roche Ag Chimärische CD4-Immunoglobulin-Polypeptide
ES2120949T4 (es) 1990-06-28 2011-12-29 Sanofi-Aventis Deutschland Gmbh 50% Proteinas de fusión con porciones de inmunoglobulinas, su preparación y empleo.
MY108267A (en) 1991-01-16 1996-09-30 Schering Corp Use of interleukin-10 in adoptive immunotherapy of cancer
US5480971A (en) 1993-06-17 1996-01-02 Houghten Pharmaceuticals, Inc. Peralkylated oligopeptide mixtures

Also Published As

Publication number Publication date
WO1998008870A1 (en) 1998-03-05
EP0963377A1 (de) 1999-12-15
DK0963377T3 (da) 2009-05-18
EP0963377B1 (de) 2009-03-04
EP2065396A1 (de) 2009-06-03
PT963377E (pt) 2009-05-11
JP2001500369A (ja) 2001-01-16
AU7155296A (en) 1998-03-19
EP0963377A4 (de) 2002-08-07
ES2322877T3 (es) 2009-06-30
DE69637856D1 (en) 2009-04-16
CA2264548A1 (en) 1998-03-05

Similar Documents

Publication Publication Date Title
DK0963377T3 (da) Interleukin-19
ATE412740T1 (de) Menschliches alpha-endokin
DK0939767T3 (da) Procin faktor VIII og hybrider deraf
EP2284189A3 (de) Fibroblasten wachstumsfaktor-ähnliche Polypeptide
DE69131580D1 (de) GDF-1 und UOG1 Proteine
DE69930955D1 (de) Polypeptide mit lysophospholipaseaktivität und nukleinesäuren die sie kodieren
ATE407949T1 (de) Charakterisierung der proteinfamilie von soc/crac kalziumkanälen
EP0670730A4 (de) Fusionsprotein, das dem rezeptor des tumornekrose-faktors enthält.
DE3382837T2 (de) Herstellung von funktionellen, menschlichen Urokinaseproteinen
ATE414775T1 (de) Polypeptide mit prolyldipeptidylaminopeptidase- aktivität und dafür kodierende nukleinsäuren
WO1998021343A8 (en) Genes encoding telomerase proteins
WO2002059315A3 (en) Human nucleic acids and polypeptides and methods of use thereof
DE69837475D1 (de) Polypeptide mit aminopeptidaseaktivität und dafür kodierende nukleinsäuren
WO2002046409A3 (en) Proteins and nucleic acids encoding same
ES545725A0 (es) Procedimiento para preparar peptidos de interferon
DK1082423T3 (da) Cyclin E2-gener og -proteiner
DK0453969T3 (de)
AU2001238064A1 (en) 18477, a human protein kinase and uses therefor
WO1994016085A3 (en) Hybrid proteins having cross-linking and tissue-binding activities
WO2002085922A3 (en) Proteins and nucleic acids encoding same
DK0708831T4 (da) Celledensitetsforstærkede proteintyrosinphosphataser
WO2002090500A3 (en) Novel human proteins, polynucleotides encoding them and methods of using the same
EP0676413A3 (de) Interferon alpha/beta bindendes Protein, seine Herstellung und Anwendung.
PT977859E (pt) O factor neurotrofico nnt-1
WO1998029438A3 (en) Cortistatin polypeptides

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0963377

Country of ref document: EP